Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Cher

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Oncology Reports|January 14, 2004
Elevated levels of angiostatin in effusions from patients with malignant diseaseRosa G Rotenberg, Natalia S Rozas, Lucía Guerri, et al.
Clinical & Experimental Metastasis|December 1, 2006
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasisSanaa M Nabha, R Daniel Bonfil, Hamilto A Yamamoto, et al.
The Prostate|August 23, 2005
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12Sreenivasa R Chinni, Sivasakthy Sivalogan, Zhong Dong, et al.
The Journal of Urology|January 30, 2019
Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate CancerKevin B Ginsburg, Rohith Arcot, Ji Qi, et al.
Scientific Reports|November 23, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growthBarani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Cancer Research|August 6, 2014
Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunityJesse J Veenstra, Heather M Gibson, Peter J Littrup, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnoverZhong Dong, Allen D Saliganan, Hong Meng, et al.
Urology|May 29, 2002
Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysisIsaac J Powell, Jyotirmoy Dey, Amanda Dudley, et al.
Molecular Cancer|November 5, 2016
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasisM Katie Conley-LaComb, Louie Semaan, Rajareddy Singareddy, et al.
Urology|April 21, 2007
Heterogeneous activation of MMP-9 due to prostate cancer-bone interactionChristoph Wiesner, R Daniel Bonfil, Zhong Dong, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Oncology Reports|January 14, 2004
Elevated levels of angiostatin in effusions from patients with malignant diseaseRosa G Rotenberg, Natalia S Rozas, Lucía Guerri, et al.
Clinical & Experimental Metastasis|December 1, 2006
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasisSanaa M Nabha, R Daniel Bonfil, Hamilto A Yamamoto, et al.
The Prostate|August 23, 2005
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12Sreenivasa R Chinni, Sivasakthy Sivalogan, Zhong Dong, et al.
The Journal of Urology|January 30, 2019
Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate CancerKevin B Ginsburg, Rohith Arcot, Ji Qi, et al.
Scientific Reports|November 23, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growthBarani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Cancer Research|August 6, 2014
Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunityJesse J Veenstra, Heather M Gibson, Peter J Littrup, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnoverZhong Dong, Allen D Saliganan, Hong Meng, et al.
Urology|May 29, 2002
Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysisIsaac J Powell, Jyotirmoy Dey, Amanda Dudley, et al.
Molecular Cancer|November 5, 2016
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasisM Katie Conley-LaComb, Louie Semaan, Rajareddy Singareddy, et al.
Urology|April 21, 2007
Heterogeneous activation of MMP-9 due to prostate cancer-bone interactionChristoph Wiesner, R Daniel Bonfil, Zhong Dong, et al.
Pageof 12